Buyer/Supply Chain Specialist (Temporary) at Visby Medical (San Jose, CA)

Visby Medical· San Jose, CA· $55–$70/hr·3d ago

Role details

Salary

$55–$70/hr

Work type

Hybrid

Employment

Contract

Job description

About Visby

San Jose based Visby Medical, Inc. is an ambitious, and fast-paced early stage biotech startup. Driven by a belief that disease diagnosis should be quick, accurate, and accessible to all, Visby Medical, Inc. is developing a novel diagnostic device platform that aims to redefine the way an infectious disease is tested and treated.

Additional information We believe that the unique contributions of all Visbees is the driver of our success. To make sure that our products and culture continue to incorporate everyone's perspectives and experience we never discriminate on the basis of race, color, religion, creed, national origin, ancestry, sex, gender, pregnancy or related medical conditions, sexual orientation, gender identity or expression, age, disability, medical condition, genetic information, marital status, or military or veteran status. Full COVID Vaccination Required - Reasonable accommodations for medical or religious reasons considered.

Why work at Visby Medical

Mission-driven: Directly impact patient outcomes by bringing rapid, accurate diagnostics to underserved settings and enabling same-visit treatment.
Ownership culture: All employees receive stock options.
Benefits: Comprehensive healthcare, 401(k) with match, flexible spending accounts, fully stocked kitchens with monthly meal stipends.
Flexibility: “Whether in an office or working remotely, it’s our goal to make everyone feel at home.” Types of arrangements not fully specified but hybrid/remote appears supported.
Development: Mentorship, ownership of meaningful projects, career growth opportunities.
Diversity: Workforce speaks 20+ languages and hails from 30+ countries; inclusive environment.
Workplace rating (LinkedIn): 2.9/5 overall (83 reviews); work-life balance scored 3.8/5, culture 3.4/5, career advancement 2.7/5 – mixed sentiment, with praise for mission but some concerns about management and career growth.

About Visby Medical

Company Overview

One-liner: Visby Medical develops the world's first instrument-free, single-use PCR test that delivers lab-quality results in under 30 minutes at the point of care.
Entity Type: Private (Later Stage VC; last round $55M in July 2025)
Headquarters: San Jose, California, USA
Founded: 2012 (incorporated as Click Diagnostics, rebranded to Visby Medical in 2020)
Founders: Adam de la Zerda (founder) and Greg Loney (founding executive, VP of Engineering)

Core Business

Primary industry: Medical diagnostics (molecular point-of-care testing)
Target customers: B2B (healthcare providers, clinics, mobile health units) & B2C (over-the-counter at-home testing, starting with sexual health)
Mission: “Empower anyone to test for any infection anywhere with near-100% accuracy.”

Products & Services

Visby Medical Sexual Health Test (2nd generation): FDA cleared and CLIA waived, instrument-free PCR test for Chlamydia, Gonorrhea, and Trichomoniasis. Available for clinical use and OTC for at-home use with telehealth support via an app.
Visby Medical Respiratory Health Test: EUA authorized for detection and differentiation of Influenza A, Influenza B, and SARS-CoV-2 (COVID-19) at the point of care.
Platform Technology: Single-use, palm-sized cartridge that performs a full 40-cycle PCR reaction without any external instrument. Results in ~30 minutes, enabling same-visit diagnosis and treatment.

Market Standing

Valuation: Not publicly disclosed
Total Funding: $435.8 million (12 rounds, per LinkedIn) – last round $55M (July 2025, led by Catalio Capital Management)
Annual Revenue: Estimated $250 million (LinkedIn figure – unverified, potentially estimated)
Notable Investors/Partners: Artiman Ventures (lead early round), Catalio Capital Management, Plug and Play, Hutchison Port Group, BARDA, NIH (RADx & AMR Diagnostic Challenge)
Growth Signals: Expanded from sexual health to respiratory panel; launched OTC at-home testing with direct-to-consumer channel; received multiple FDA authorizations and prestigious government awards (e.g., $19M overall winner of the AMR Diagnostic Challenge, $12.3M BARDA award, $10M NIH RADx). Headcount estimates conflict: LinkedIn reports 111 employees (YoY -8.2%), PitchBook reports 208 employees.

Competitive Advantages

True PCR in a handheld, instrument-free format: Competitors often rely on isothermal amplification or separate readers; Visby miniaturises high-fidelity PCR (40 cycles) into a single-use cartridge.
Speed + Accuracy: Delivers lab-equivalent sensitivity/specificity in under 30 minutes – eliminates days-long lab wait times and reduces loss to follow-up.
Portability and Scalability: No bulky equipment, no maintenance, easy to deploy in any clinical setting or remote location.
First FDA clearance + CLIA waiver for an instrument-free PCR sexual health test – strong regulatory moat.

Strategic Focus

Expand the menu of tests to cover more infectious diseases (e.g., respiratory, sexually transmitted, potentially antimicrobial resistance markers).
Scale the OTC at-home channel (starting with women’s sexual health) to reach consumers directly.
Continue to win public health contracts (BARDA, NIH) and establish partnerships with health systems, urgent cares, and mobile clinics.

Sources

visbymedical.com – Company history and product timeline
visbymedical.com – Home page, product features, awards
visbymedical.com – Culture and benefits overview
linkedin.com – Employee count, revenue, funding, reviews
pitchbook.com – Latest funding, employee count (208), company profile

Job description

About Visby

Why work at Visby Medical

Application questions